The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
.... would sell at the moment unless they were desperate for cash??? Incredibly low market cap as Kidlington and Laura rightly point out and possibly massive Artificial intelligence side as Laura points out. I think we could well reach 3p today as Brighty said. Wouldn't it be nice if Merck were Bout to bid a buyout at 20p per share??? Bring it on
?
Approaching 2% of the companies shares bought today with very little in terms of sells.
New uncle. And long may that buying continue!!!
Buying is continuous.....
NT trade for just 12000 shares. Hopefully something positive is going on.
3p is very possible here in just 1 session. A few more contract gains and we will be back at the 52 week high of 6.60p and that's before things really start to take off....
Good luck, Brighty
Not even £1k in sells. Interesting morning.
C18% on low volume
Moving with buys and fast too
You moved it Laura.....well done
This morning with profits from FCS
Thanks msuk/sienna
Msuk. Thanks for that
Kept above the 50ema D bullish bias looking for the break above that triangle for BO test the highs of c2.778
Msuk. What is the interpretation of it please?
Hi Mark
What does that black triangle mean ?
Is I t a good symbol ?
A.I yet again developing and I'm sure we are in the frame given the comments from Jim Millen at the end of the last PYC Merck RNS
Interesting tie ups in the last few days.
https://www.fiercebiotech.com/biotech/merck-kgaa-doubles-ai-partners-tapping-benevolentai-and-exscientia-drug-discovery-push .
Obviously nothing to do with us, thou we have a partnership with Merck.
Beyond Blood is just one option for their dosing tool,this was from the January news item
NEXT STEPS
There are multiple ways in which the results of the PARTNER study can be leveraged:
· Academic dissemination; the insights gained from the PARTNER study will form the basis of several posters and/or publications
· The exploring of solutions for point of care blood testing that could address the limitation noted above. Physiomics has already identified a number of technologies in development that could be the basis for a hardware/ software collaboration
· Exploring other applications of the tool in settings where regular attendance at hospital for additional tests is not an obstacle because it is already required as part of current standard of care or because the use of the drug requires careful monitoring; examples could include:
o Paediatric applications where it is important to maintain certain cell types within strict limits
o Patients with haematological malignancies
o Patients undergoing chemotherapy in combination with radiotherapy
You could not buy at 1.8p at the last few minutes
Yep. Showing as a buy. They must have seen my message!!! Hoping to get over 2p tmw
Interims due approx 26th
1.799 paid at the death.
however will go down tomorrow as if i am lucky enough to top up at the bottom.
good luck all holders